Delandistrogene moxeparvovec
Drug timelines are a Plus or Pro feature.
8 regulatory and trial events tracked for Delandistrogene moxeparvovec, covering 2023-09-15 to 2026-02-10. Get the full timeline:
Most recent: Clinical Trial Update: A Gene Delivery Study to Evaluate the Safety and Expression of Delandistrogene Moxeparvovec in Participants Under the Age of Four With Duchenne Muscular Dystrophy (DMD) [Phase 2]